|
DOSSIER: SCIENCE, INDUSTRY AND CHARITIES AROUND DIPHTHERIA SEROTHERAPY IN FRANCE AND GERMANY
(Edición a cargo de Esteban Rodríguez-Ocaña ) |
|
Esteban Rodríguez-Ocaña . La producción social de la novedad: el suero antidiftérico, «nuncio de la nueva medicina»
|
|
Gabriel Gachelin. The designing of anti-diphtheria serotherapy at the Institut Pasteur (1888-1900): the role of a supranational network of microbiologists
Sumario
1.—Introduction. 2.—Shuttling of research on diphtheria between France and Germany. 3.—The designing of French standards and norms in accordance with German ones. 4.—The rapid decline of strong anti-German feelings at the Insti¬ tut Pasteur.
|
|
Jonathan Simon . The origin of the production of diphtheria antitoxin in France, between philantropy and commerce
Summary
1.—Introduction. 2.—The origins of the serum. 3.—The production process. 4.—Serum at the Pasteur Institute; the pros and cons of media exposure. 5.— The serum and the finances of the Pasteur Institute. 6.—The serum legislation. 7.—French culture and the serum industry. 8.—Conclusion: serum in European cultures.
|
|
Annick Opinel . The Pasteur Hospital as an element of Emile Roux`s anti-diphtheria apparatus (1890-1914)
Sumario
1.—Introduction. 2.—The context of the development of serotherapy against diphtheria. 3.—Roux’s project. 4.—The production site of the serum: Marnes-la-Coquette (Garches). 5.—The Hôpital Pasteur. 5.1.—Financing. 5.2.—The order. 5.3.—The architect. 5.4.—Description. 5.5.—Internal distribution and circulation. 5.6.—Influence and inspirations. 6.—The Hôpital Pasteur as a model. 7.—Contes-tation of the model. 7.—The Hôpital Pasteur: an expensive ideal.
|
|
Axel C. Hüntelmann . Diphtheria serum and serotherapy. Development, production and regulation in fin de siècle Germany
Sumario
1.—Introduction. 2.—The socio-cultural context of science in fin de siècle Ger¬many. 3.—The development of the diphtheria serum in Germany. 4.—The production of diphtheria serum in the German empire. 5.—State control of di¬phtheria serum. 6.—Serum networks and indirect state regulation.
|
|